Skip to main content
. 2022 Oct 28;14(21):5319. doi: 10.3390/cancers14215319

Figure 1.

Figure 1

Model and treatment designs. (a) Model schematic of treatment resistance stem cells, sensitive non-stem cells, and prostate-specific antigen interactions. (b) Adaptive therapy treatment design. (c) Range-bounded adaptive therapy treatment design.